Location: Home
  • search
  • go
  • Relate News
  • 10/24/2018Draft Amendment of the Drug Administration Law under Review by the NPC
  • 10/24/2018CANbridge and WuXi Biologics Enter into Rare Disease Partnership
  • 10/23/2018IQVIA: Chinese Retail Pharmacy Market Surged 3.9% in MAT Q2/2018
  • 10/23/2018Healthcare Sector Growth Slows in First Three Quarters of 2018
  • 10/23/2018China Is Funding the Future of American Biotech
  • 10/23/2018China Electronics Data and WuXi AppTec Form Healthcare Big Data JV
  • 10/18/2018Chi-Med Starts Phase I Study of HMPL-523 for Leukemia In China
  • 10/18/2018Recent Executive Moves
  • 10/18/2018IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q2/2018
  • 10/18/2018NHC Drafts Plan to Boost Overall Clinical Appraisal of Drug Products
  • 10/17/2018Eisai's NDA for Antiepileptic Perampanel Accepted in China
  • 10/16/2018DiaMedica and Fosun Subsidiary Signs License Agreement for Stroke Medi...
  • 10/16/2018Alphamab's HER2 Bispecific Antibody KN026 Gains US IND
  • 10/16/2018CStone Receives U.S. IND Approval for PD-L1 Antibody CS1001
  • 10/15/2018How to Fulfill China’s Potential for Carrying Out Clinical Trials
  • 10/15/2018Innovent Granted Chinese IND for Sintilimab/Bevacizumab Combinaiton Th...
  • 10/15/2018Zheijiang Huahai Placed under Increased Supervision
  • 10/15/2018Exploring Ways to Establish Presence in China as Part of APAC Region P...
  • 10/12/2018Eisai's NDA for Antiepileptic Drug Perampanel Accepted in China
  • 10/12/2018Mesoblast and Tasly Complete Strategic Cardiovascular Partnership in C...
  • 10/11/2018NEJM and CCA Enter Partnership for CVS Research and Training
  • 10/11/2018MEI Pharma and BeiGene Announce Collaboration for ME-401/Zanubrutinib ...
  • 10/10/2018SMIA Issues Official Notice on Approval of 17 Anticancer Drugs for BMI...
  • 10/9/2018Daiichi Sankyo Enters Deal with MVP for Distribution of Pain Medicine ...
  • 10/9/2018Listed Chinese Pharma Cos Reports Positive Performance in H1
  • 10/8/2018CDE Solicits Comments on Technical Requirements for Manufacturing Site...
  • 10/8/2018NMPA Issues Rules for Communications Related to Drug R&D and Techn...
  • 10/8/2018Biosimilars and Healthcare Policy: What China Can Learn from the EU an...
  • 10/8/2018Amyris Enters into Extensive Partnership with Yifan Pharma
  • 10/8/2018Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs
  • Page:158/361 Total number of articles:10826: [First][<<] [156] [157] [158] [159] [160] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group